Welcome to the Divis Labs Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...
Stay up-to-date with the Divis Labs Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...
Divis Laboratories Ltd is quoting at Rs 6125.5, down 1.77% on the day as on 13:19 IST on the NSE. The stock jumped 2.08% in last one year as compared to a 9.4% rally in NIFTY and a 0.15% fall in the ...
Divis Laboratories organised a road safety rally in Bheemunipatnam, promoting safe driving and traffic rule adherence among participants.
Amid the rising volatility in the Indian equity markets, domestic brokerage firm BP Equities has shared its top picks for January 2026 on a techno-funda basis. These include names like Bharat ...
NDTV Profit on MSN
Five Stocks To Buy: BEL, Asian Paints, Divi's Labs And More
Analysts give a range of buy calls across defence, paints, pharma, commodities, and auto stocks.
Trade Brains on MSN
Is 2026 a turning point for Divis Laboratories? Here's what Citi says about the pharma stock
India, Jan. 15 -- The shares of this pharma stock, engaged in the manufacturing and exporting of API's and Nutraceutical ingredients, are in focus after leading global brokerage, CITI, has expressed ...
NDTV Profit on MSN
Five Stocks To Buy: Divi's Labs, Aurobindo Pharma, Britannia And More
Multiple experts are converging on select pharma, FMCG, media, and financial services counters. Key names on today’s radar include Divi’s Laboratories, Aurobindo Pharma, and Britannia Industries.
The Indian pharmaceutical and life sciences sector entered FY26 after a reform-oriented Union Budget 2025 that focused on tax ...
Net Loss of Suryo Foods & Industries reported to Rs 0.06 crore in the quarter ended December 2025 as against net loss of Rs 0.01 crore during the previous quar ...
Get all latest & breaking news on Hemang Jani. Watch videos, top stories and articles on Hemang Jani at moneycontrol.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results